This announcement is a separate document:
迪哲医药：华泰联合证券有限责任公司关于迪哲（江苏）医药股份有限公司2023年年度持续督导跟踪报告
Dizal: Huatai United Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Dighe (Jiangsu) Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.